Canadian microultrasound technology developer Exact Imaging has formed a strategic partnership with nonprofit scientific research company Riverside Research.
Riverside Research's quantitative tissue-characterization algorithms will be applied to Exact's ExactVu microultrasound platform in the hope of developing new capabilities for detecting and characterizing prostate cancer, according to the companies.